Annexin II: a plasminogen-plasminogen activator co-receptor.
about
Cellular receptors for human enterovirus species aSecretion without GolgiThe intracellular translocation of the components of the fibroblast growth factor 1 release complex precedes their assembly prior to exportCombination Low-Dose Tissue-Type Plasminogen Activator Plus Annexin A2 for Improving Thrombolytic Stroke TherapyProtein folding does not prevent the nonclassical export of FGF1 and S100A13Tyrosine 23 phosphorylation-dependent cell-surface localization of annexin A2 is required for invasion and metastases of pancreatic cancerLaser capture microdissection-based in vivo genomic profiling of wound keratinocytes identifies similarities and differences to squamous cell carcinomaEffect of water-soluble fraction of cigarette smoke on human aortic endothelial cells--a proteomic approach.Expression of angiostatin cDNA in human gallbladder carcinoma cell line GBC-SD and its effect on endothelial proliferation and growth.Annexin A2 tetramer activates human and murine macrophages through TLR4.Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury.Cell surface translocation of annexin A2 facilitates glutamate-induced extracellular proteolysisExophagy of annexin A2 via RAB11, RAB8A and RAB27A in IFN-γ-stimulated lung epithelial cells.Annexin A2 combined with low-dose tPA improves thrombolytic therapy in a rat model of focal embolic stroke.The receptor for beta(2)GP I on membrane of hepatocellular carcinoma cell line SMMC-7721 is annexin IIAnnexin A2: a tissue plasminogen activator amplifier for thrombolytic stroke therapy.Plasminogen is a joint-specific positive or negative determinant of arthritis pathogenesis in miceAnti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis.Domains I and IV of annexin A2 affect the formation and integrity of in vitro capillary-like networks.Mutant K-ras regulates cathepsin B localization on the surface of human colorectal carcinoma cells.A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events.Identification of novel viral receptors with cell line expressing viral receptor-binding protein.Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity.Hypoxia increases Annexin A2 expression in osteoblastic cells via VEGF and ERK.Live-cell imaging of tumor proteolysis: impact of cellular and non-cellular microenvironmentGlutathione analogues in cancer treatment.Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay.Tissue plasminogen activator activates NF-κB through a pathway involving annexin A2/CD11b and integrin-linked kinase.Tyrosine 23 Phosphorylation of Annexin A2 Promotes Proliferation, Invasion, and Stat3 Phosphorylation in the Nucleus of Human Breast Cancer SK-BR-3 Cells.PAI-1 and kidney fibrosis.Plasmin enhances cell surface tissue factor activity in mesothelial and endothelial cells.Reduced clearance of respiratory syncytial virus infection in a preterm lamb model.Effects of tissue plasminogen activator and annexin A2 combination therapy on long-term neurological outcomes of rat focal embolic stroke.The endothelial cell annexin A2 system and vascular fibrinolysis.Plasminogen and its receptors as regulators of cardiovascular inflammatory responses.The placenta in toxicology. Part I: Animal models in toxicology: placental morphology and tolerance molecules in the cynomolgus monkey (Macaca fascicularis).The spectrum of translational stroke research.Tissue plasminogen activator and inflammation: from phenotype to signaling mechanisms.CNS macrophages and peripheral myeloid cells in brain tumours.The inflammatory actions of coagulant and fibrinolytic proteases in disease.
P2860
Q21131148-3164E2A7-610B-4EA0-967D-8C56DD588AAFQ24654691-23C1C9C8-CF15-4779-98F1-504E6944C5D3Q24673957-9A32AEBF-469B-4D0E-BA6C-6A81271426CFQ26777274-DD8F20B5-049D-4F25-8E8F-D8101849BA78Q28511093-82392A40-D722-41E6-9A77-4A0694C2C0E6Q28740545-3A439A7A-73C2-4A49-80DF-6ACBF8BF3591Q31147032-A14022AB-1736-4741-B0C8-5AD078AFD579Q31168127-3509FAC5-4928-4AC9-B71A-E4517B5F9864Q33244333-17274E0A-4ABB-4A96-A96F-35E4002D02B8Q33608764-F932B1B0-1591-4B24-88BB-2C32EE008ACEQ33646877-C9972230-2F80-40D9-BB82-EF726207DA5EQ33718405-D07B6E95-0EF5-4868-B4BF-8E3F7ACC0A76Q33916191-4E74614C-939C-48F0-8B9E-650E9A320664Q34171180-59A3D226-5149-4763-8082-AB5A932FC8C7Q34233062-FC28B12A-16C7-43D8-8154-B07A6FB1AAAFQ34363696-4A912865-83B8-4C3E-BC0D-E87CF2A388F8Q34383596-8040D8BA-2FFB-4270-9CDF-C689E5A61CAEQ34457056-B857088D-8C4D-4951-B0D0-A8781D8F6FCCQ34653675-05C9A96A-EDC6-44C5-8573-175A894CE3B3Q34773206-C2E7F7EA-9A8C-4E48-A476-B1D0C911998CQ34808641-914B4524-A658-446A-A10B-6669AAC76B01Q34990603-B85A27EF-31F5-4454-95EA-DAF0FDB964EAQ35531212-2EAE63D2-CD6A-49A2-B5D2-E000F2A4343AQ35570877-62BFC39D-BB3C-4CB4-AA14-DBED4BF7AE0EQ35597185-0C62A65A-4911-4DEF-BEFD-416D3573AA3DQ35642624-BC32E519-6343-495B-B2AB-3C8281B329A1Q35792021-87C0EAA7-CCC9-4958-A985-2935F1D85834Q36109173-985146B8-65FB-43BE-9015-A5474F9B1264Q36814450-B200E0CE-18BB-48BA-AD62-1F6165C53A90Q36846526-1F78F176-5CAA-4015-8042-66DA916D634DQ37020416-24D6D038-6221-4644-A60E-6B261151A321Q37467911-05B815E3-675E-41FF-9147-05B14805D7BAQ37549827-2950E31E-1407-4DDA-867E-AC5477AE074BQ37679552-C746CB21-1E21-4F03-A1F3-B37839811BA3Q37844995-985A7C01-CFEF-4980-A64F-005452938EFDQ38095221-7BB321D6-FBC3-4B34-89A4-1DEB6BCCA72BQ38099697-ED19EACC-30C3-4217-8DE5-EDAFDDBC0123Q38198639-E6713525-CD04-4F6E-8A89-428C9111D5D9Q38203815-1AAF57EF-6A01-4274-A156-C309045F41E1Q38423064-9B1F78D0-C0A7-40D1-963B-66AE2D741596
P2860
Annexin II: a plasminogen-plasminogen activator co-receptor.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Annexin II: a plasminogen-plasminogen activator co-receptor.
@ast
Annexin II: a plasminogen-plasminogen activator co-receptor.
@en
Annexin II: a plasminogen-plasminogen activator co-receptor.
@nl
type
label
Annexin II: a plasminogen-plasminogen activator co-receptor.
@ast
Annexin II: a plasminogen-plasminogen activator co-receptor.
@en
Annexin II: a plasminogen-plasminogen activator co-receptor.
@nl
prefLabel
Annexin II: a plasminogen-plasminogen activator co-receptor.
@ast
Annexin II: a plasminogen-plasminogen activator co-receptor.
@en
Annexin II: a plasminogen-plasminogen activator co-receptor.
@nl
P356
P1476
Annexin II: a plasminogen-plasminogen activator co-receptor.
@en
P2093
Katherine A Hajjar
P304
P356
10.2741/KIM
P577
2002-02-01T00:00:00Z